Search results for diagnostics

“While both can be useful (depending on context), they have different implications: much like a person's glucose may fluctuate throughout the day, standard lab measures of omega-3 rely on plasma, biasing them to the content of a recent meal.”

Dr. Rhonda Patrick discusses nicotinamide riboside, biomarkers, belly fat loss, sex-specific health, curcumin & ashwagandha safety.

“The findings support working on several modifiable factors together, while leaving open how much each component contributes and whether these changes prevent an eventual Alzheimer's diagnosis.”

“The modeled relationship between vigorous and moderate activity varied by outcome: one vigorous minute corresponded statistically to 4.1 moderate minutes for all-cause mortality, 7.8 for cardiovascular mortality, 3.5 for mortality from selected activity-related cancers, and 1.6 for cancer incidence.”

Dr. Rhonda Patrick answers audience questions on various health, nutrition, and science topics in this Q&A session.

“National survey analyses estimated that roughly 38% to 47% of Americans consumed less vitamin C than the Estimated Average Requirement across 1999–2018, while an earlier biomarker survey found clinical vitamin C deficiency in about 7%.”

“FTA: > Researchers in the US have developed a new Alzheimer’s blood test that could pick up on the very early stages of Alzheimer’s disease with 100 percent accuracy when tested on 174 individuals.”

“FTA: > More than two-thirds (69 per cent) of bowel cancer patients say they weren’t advised to exercise regularly after their diagnosis – despite evidence that brisk physical activity is linked to better survival in bowel cancer, according to a study.”

“New Scientist article. 02:06:10 - Some people, like Tom Cruise and Keanu Reeves, seem to defy aging. 02:08:15 - One 12-ounce can of sugar-sweetened soft drink per day shortened telomere length, corresponding to 4.6 years of biological aging.”

“Roughly 50 million people have Alzheimer's disease worldwide. Researchers have developed a blood test that measures phospho-tau217 (p-tau217), a type of tau protein, and may be useful in diagnosing Alzheimer's disease as early as 20 years before symptoms manifest.”